Inflammatory signals from fatty bone marrow supports the early stages of DNMT3a driven clonal hematopoiesis
N. Zioni, A. Bercovich, N. Chapal-Ilani, A. Solomon, E. Petrovich, M. .Sacma, H. Geiger, M. Scheller, C. Müller-Tidow, D. Lipka, E. Shlush, M. Minden, N. Kaushansky, L. Shlush
Abstract
Age related cancer is not only due to the random accumulation of mutations, but also how phenotypes are selected by the aging environment. While fatty bone marrow (FBM), is one of the hallmarks of bone marrow ageing, it is unknown whether FBM can modify the evolution of the early stages of leukemia and clonal hematopoiesis (CH). To address this question, we established FBM mice models and transplanted both human and mice preleukemic hematopoietic stem cells (PreL-HSCs) carrying DNMT3A mutations. We demonstrate that castration which models age related andropenia result in FBM. A significant increase in self-renewal was found when DNMT3AMut - preL-HSPCs were exposed to FBM. To better understand the mechanisms of the FBM-preL-HSPCs interaction, we performed single cell RNA-sequencing on HSPCs three days after FBM exposure. A 20-50 fold increase in DNMT3AMut-preL-HSCs was observed under FBM conditions in comparison to other conditions. PreL-HSPCs exposed to FBM exhibited an activated inflammatory signaling (IL-6 and INF{gamma}). Cytokine analysis of BM fluid demonstrated increased IL-6 levels under FBM conditions. Anti-IL-6 neutralizing antibodies significantly reduced the selective advantage of DNMT3AMut-preL-HSPCs exposed to FBM. Overall, age related paracrine FBM inflammatory signals promote DNMT3A-driven clonal hematopoiesis, which can be inhibited by blocking the IL-6 receptor.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Oncostatin M is a Master Regulator of an Inflammatory Network in Dnmt3a-Mutant Hematopoietic Stem Cells
L. S. Schwartz, K. A. Young, … J. J. Trowbridge·bioRxiv·Jul 12, 2023
- Retrotransposons Promote Dnmt3a-Mutant Clonal Hematopoiesis Through Aging-Related Stromal Inflammation
Qiongdi Zhang, Wenhuo Hu, … Sisi Zheng·bioRxiv·Jul 2, 2026
- Mesenchymal Stromal Cell Senescence Induced by Dnmt3a-Mutant Hematopoietic Cells is a Targetable Mechanism Driving Clonal Hematopoiesis and Initiation of Hematologic Malignancy
Jayna J. Mistry, Kira A. Young, … Jennifer J. Trowbridge·bioRxiv·Mar 28, 2024
- Proteostasis Stress Drives Stem Cell Aging, Clonal Hematopoiesis and Leukemia
Fanny Zhou, Michelle K. Le, … Robert A. J. Signer·bioRxiv·Nov 27, 2025
- Neutrophil-Derived S100A8/A9 Drives Inflammation that Promotes Dnmt3a -Mutant Hematopoiesis
Jayna J. Mistry, Natalie R Fournier, … Jennifer J. Trowbridge·bioRxiv·Jun 27, 2026
- Distinct causes of three phenotypic hallmarks of hematopoietic aging
Dennis J. Chia, Apeksha Singh, … Alexander Hoffmann·Cell ReportsPeer-reviewed·Aug 26, 2025